Elise Maubert Selected Research

Extraskeletal Myxoid Chondrosarcoma

1/2021	Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcoma.
1/2020	Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elise Maubert Research Topics

Disease

5	Hypoxia (Hypoxemia) 01/2021 - 01/2017
4	Chondrosarcoma 01/2021 - 01/2017
3	Neoplasms (Cancer) 01/2021 - 01/2017
2	Extraskeletal Myxoid Chondrosarcoma 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

4	ProdrugsIBA 01/2021 - 01/2017
3	Proteoglycans (Proteoglycan)IBA 01/2021 - 10/2018
2	ICF05016IBA 01/2021 - 01/2020
2	Ammonium CompoundsIBA 01/2020 - 10/2018
2	Aggrecans (Aggrecan)IBA 01/2020 - 10/2018
1	APTIBA 01/2021
1	Contrast MediaIBA 01/2021
1	fluoromisonidazoleIBA 01/2021
1	N-(triethylammonium)-3-propyl(15)ane-N5IBA 01/2021
1	imidazoleIBA 01/2020
1	azomycinIBA 01/2020
1	LigandsIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	GlycosaminoglycansIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	pimonidazoleIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	TH 302IBA 01/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 10/2018
1	Radiotherapy 01/2021
1	Therapeutics 10/2018